• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Interruptions of high-dose radiation therapy decrease the long-term survival of favorable patients with unresectable non-small-cell carcinoma of the lung. Analysis of 1244 cases from radio-oncology (RTOG) studies. Radiation Therapy Oncology Group].

作者信息

Herrmann T

出版信息

Strahlenther Onkol. 1994 Sep;170(9):551-2.

PMID:7940128
Abstract
摘要

相似文献

1
[Interruptions of high-dose radiation therapy decrease the long-term survival of favorable patients with unresectable non-small-cell carcinoma of the lung. Analysis of 1244 cases from radio-oncology (RTOG) studies. Radiation Therapy Oncology Group].
Strahlenther Onkol. 1994 Sep;170(9):551-2.
2
Radiation therapy in the management of patients with unresectable stage IIIA and IIIB non-small cell lung cancer.
Semin Oncol. 1997 Aug;24(4):423-8.
3
[The state of the art: radiation therapy for non-small cell lung cancer].
Gan To Kagaku Ryoho. 1997 Oct;24 Suppl 3:373-8.
4
Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.肿瘤体积增大预示着总生存期和无进展生存期较差：放射肿瘤学组93-11 I-II期放射剂量递增研究对无法手术的非小细胞肺癌患者的二次分析。
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):385-90. doi: 10.1016/j.ijrobp.2007.06.034. Epub 2007 Sep 14.
5
Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.血清标志物能否用于预测肺癌患者的急性和晚期毒性？RTOG 91-03分析。
Am J Clin Oncol. 2007 Aug;30(4):368-76. doi: 10.1097/01.coc.0000260950.44761.74.
6
High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study.高剂量放疗改善了不可手术/无法切除的非小细胞肺癌患者的局部肿瘤控制和总生存期：一项放疗剂量递增研究的长期结果
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):324-33. doi: 10.1016/j.ijrobp.2005.02.010.
7
Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.局部晚期非小细胞肺癌同步放化疗后总治疗时间对疗效的影响：放射肿瘤学组（RTOG）经验分析
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):667-71. doi: 10.1016/j.ijrobp.2005.03.037. Epub 2005 May 31.
8
Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.放射治疗肿瘤学组（RTOG）9311的毒性反应和结果：一项针对无法手术的非小细胞肺癌患者采用三维适形放疗的I-II期剂量递增研究。
Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):318-28. doi: 10.1016/j.ijrobp.2004.06.260.
9
A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.一项针对身体状况不佳、无法手术/不可切除的非小细胞肺癌患者的胸部放疗联合塞来昔布的I期临床试验。
Clin Cancer Res. 2005 May 1;11(9):3342-8. doi: 10.1158/1078-0432.CCR-04-1741.
10
[Current approaches to the use of radiotherapy in patients with non-small-cell lung cancer].[非小细胞肺癌患者放疗的当前应用方法]
Vopr Onkol. 1998;44(5):623-8.

引用本文的文献

1
Analysis of the risk factors for myelosuppression after concurrent chemoradiotherapy for patients with advanced non-small cell lung cancer.分析晚期非小细胞肺癌患者同步放化疗后骨髓抑制的危险因素。
Support Care Cancer. 2013 Mar;21(3):785-91. doi: 10.1007/s00520-012-1580-y. Epub 2012 Aug 31.